FK506 Binding Proteins as Targets in Anticancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 9, 2010-11 ,pp. : 651-656

Bentham Science Publishers

Access to resources Recommend Favorite

A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer

By Ding Cuimin   Li Ruijuan   Peng Jingcui   Li Shengmian   Guo Zhanjun  

Experimental and Therapeutic Medicine, Vol. 3, Iss. 4, 2012-04 ,pp. : 689-692

Spandidos Publications

Access to resources Recommend Favorite

Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B

By Allegra Alessandro   Penna Giuseppa   Alonci Andrea   Granata Angela   D’Angelo Arianna   Musolino Caterina  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 912-914

Humana Press, Inc

Access to resources Recommend Favorite

MHC class I-related chain B gene polymorphism is associated with virological response to pegylated interferon plus ribavirin therapy in patients with chronic hepatitis C infection

By  

Biomedical Reports, Vol. 3, Iss. 2, 2015-01 ,pp. : 247-253

Science Publishers

Access to resources Recommend Favorite

Single-nucleotide polymorphism of the UMOD promoter is associated with the outcome of chronic kidney disease patients

By              

Biomedical Reports, Vol. 3, Iss. 4, 2015-01 ,pp. : 588-592

Science Publishers

Access to resources Recommend Favorite